2023-11-01T18:29:05+03:00[Europe/Moscow] en true <p>a</p>, <p>b</p>, <p>vitamin d, iPTH, phsophorus, calcium </p>, <p>8.5-10.2 mg/dL</p>, <p>2.7-4.6 mg/dL</p>, <p>14-64 pg/ml</p>, <p>&gt; 20 ng/ml</p>, <p>restriction of dietary phosphorus intake; &lt; 800-1000 mg/day</p>, <p>CKD + persistent hyperphosphatemia </p>, <p>must administer with meals to be effective; titrated every 2-3 weeks until PO4 levels are normalized ; take other meds 1-2 hrs before or 3 hrs after </p>, <p>oral calcium binders</p>, <p>1500 mg</p>, <p>200 mg</p>, <p>169 </p>, <p>resin binders </p>, <p>ferric citrate, sevelamers </p>, <p>d</p>, <p>potential for systemic/GI accumulation if taken whole </p>, <p>aluminum hydroxide </p>, <p>&lt; 4 weeks </p>, <p>a</p>, <p>serum calcium, risk for calcifications, iron status, pill burden, cost, formulation</p>, <p>&lt;30 ng/mL</p>, <p>CKD + hemodialysis </p>, <p>inactive vitamin D</p>, <p>50,000 IU weekly x 6-12 weeks </p>, <p>800-2000 IU daily</p>, <p>25(OH)D, calcium, phosphorus, PTH</p>, <p>sevelamer carbonate, sevelamer hydrochloride </p>, <p>ferric citrate, sucroferric oxyhydroxide </p>, <p>c</p>, <p>CKD stage: 3-4</p>, <p>CKD stage 4-5 + persistently high PTH + hemodialysis </p>, <p>Hypercalcemia/hyperphosphatemia; nutritional vitamin D supplements</p>, <p>ESRD + hemodialysis </p>, <p>serum calcium &lt; 8.4</p>, <p>CYP3A4; CYP2D6</p>, <p>vitamin D, calcium (early CKD) </p>, <p>phosphorus, calcium (late CKD)</p> flashcards
CKD-MBD (Therapeutics)

CKD-MBD (Therapeutics)

  • a

    Which is due to consistently high PTH levels? (high bone turnover)

    a) Ostetitis Fibrosa Cystica

    b) Adynamic bone disease

  • b

    Which is due to oversuppressed PTH levels? (low bone turnover)

    a) Ostetitis Fibrosa Cystica

    b) Adynamic bone disease

  • vitamin d, iPTH, phsophorus, calcium

    Which lab tests do we use for CKD-MBD? (4)

  • 8.5-10.2 mg/dL

    What is the normal range for Corrected Ca?

  • 2.7-4.6 mg/dL

    What is the normal range for phosphate?

  • 14-64 pg/ml

    What is the normal range for iPTH?

  • > 20 ng/ml

    What is the normal range for 25(OH)D?

  • restriction of dietary phosphorus intake; < 800-1000 mg/day

    What is the nonpharmalogical recommendations for CKD-MBD?

  • CKD + persistent hyperphosphatemia

    What is the indication for Phosphate binders?

  • must administer with meals to be effective; titrated every 2-3 weeks until PO4 levels are normalized ; take other meds 1-2 hrs before or 3 hrs after

    What is the counseling for Phosphate Binders? (3)

  • oral calcium binders

    What is the 1st line option in patients WITHOUT hypercalcemia?

  • 1500 mg

    What is the max dose of elemental calcium per day?

  • 200 mg

    What is the elemental calcium for Calcium Carbonate?

  • 169

    What is the elemental calcium for Calcium Acetate?

  • resin binders

    What is the first-line option for patients WITH hypercalcemia or risk of

    calcifications?

  • ferric citrate, sevelamers

    Which binders must be taken whole? (2)

  • d

    Which must be chewed?

    a) calcium carbonate

    b) Sevelamer Carbonate

    c) Ferric citrate

    d) Sucroferric oxyhydroxide

    e) Sevelamer hydrochloride

    f) calcium acetate

  • potential for systemic/GI accumulation if taken whole

    What are the potential risks associated with Lananthum?

  • aluminum hydroxide

    What is the last line option due to toxicity?

  • < 4 weeks

    How long can a patient use Aluminum Hydroxide?

  • a

    Which has drug interactions with PPIs & H2 blockers?

    a) calcium carbonate

    b) Sevelamer Carbonate

    c) Ferric citrate

    d) Sucroferric oxyhydroxide

    e) Sevelamer hydrochloride

    f) calcium acetate

  • serum calcium, risk for calcifications, iron status, pill burden, cost, formulation

    What are the considerations when choosing a phosphate binder? (6)

  • <30 ng/mL

    Which patients are indicated for Vitamin D supplementation?

  • CKD + hemodialysis

    Which patients should NOT be using Inactive vitamin D?

  • inactive vitamin D

    Which form of vitamin D should be used in patients NOT on hemodialysis?

  • 50,000 IU weekly x 6-12 weeks

    What is the initial treatment dose? (Inactive Vitamin D)

  • 800-2000 IU daily

    What is the maintenance dose for Inactive Vitamin D?

  • 25(OH)D, calcium, phosphorus, PTH

    What monitoring must be done for patients on vitamin D supplementation? (4)

  • sevelamer carbonate, sevelamer hydrochloride

    What are the Resin binders? (2)

  • ferric citrate, sucroferric oxyhydroxide

    What are the iron based binders? (2)

  • c

    Which can helpful in patients with iron deficiency?

    a) calcium carbonate

    b) Sevelamer Carbonate

    c) Ferric citrate

    d) Sucroferric oxyhydroxide

    e) Sevelamer hydrochloride

    f) calcium acetate

  • CKD stage: 3-4

    What is the indication for Calcifediol?

  • CKD stage 4-5 + persistently high PTH + hemodialysis

    What is the indication for Vitamin D analogs?

  • Hypercalcemia/hyperphosphatemia; nutritional vitamin D supplements

    _________ is a bigger concern with Vitamin D analogs than __________.

  • ESRD + hemodialysis

    What is the indication for Calcimimetics?

  • serum calcium < 8.4

    When do we NOT initiate a Calcimimetic?

  • CYP3A4; CYP2D6

    Cinacalcet is metabolized by ________ and is a potent inhibitor of ________.

  • vitamin D, calcium (early CKD)

    Which labs will decrease? (2)

  • phosphorus, calcium (late CKD)

    Which labs will increase? (2)